scope ophthalmics limited

Live EstablishedLargeHigh

scope ophthalmics limited Company Information

Share SCOPE OPHTHALMICS LIMITED

Company Number

07883194

Shareholders

scope opthalmics ltd

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

 

Registered Address

unit 4 amberley court, county oak way, crawley, RH11 7XL

scope ophthalmics limited Estimated Valuation

£44.2m

Pomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £44.2m based on a Turnover of £46.6m and 0.95x industry multiple (adjusted for size and gross margin).

scope ophthalmics limited Estimated Valuation

£7.9m

Pomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £7.9m based on an EBITDA of £901.9k and a 8.81x industry multiple (adjusted for size and gross margin).

scope ophthalmics limited Estimated Valuation

£15.1m

Pomanda estimates the enterprise value of SCOPE OPHTHALMICS LIMITED at £15.1m based on Net Assets of £8m and 1.89x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Scope Ophthalmics Limited Overview

Scope Ophthalmics Limited is a live company located in crawley, RH11 7XL with a Companies House number of 07883194. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in December 2011, it's largest shareholder is scope opthalmics ltd with a 100% stake. Scope Ophthalmics Limited is a established, large sized company, Pomanda has estimated its turnover at £46.6m with high growth in recent years.

View Sample
View Sample
View Sample

Scope Ophthalmics Limited Health Check

Pomanda's financial health check has awarded Scope Ophthalmics Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

5 Strong

positive_score

4 Regular

positive_score

3 Weak

size

Size

annual sales of £46.6m, make it larger than the average company (£24.7m)

£46.6m - Scope Ophthalmics Limited

£24.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 17%, show it is growing at a faster rate (5.3%)

17% - Scope Ophthalmics Limited

5.3% - Industry AVG

production

Production

with a gross margin of 29.7%, this company has a comparable cost of product (29.5%)

29.7% - Scope Ophthalmics Limited

29.5% - Industry AVG

profitability

Profitability

an operating margin of 1.9% make it less profitable than the average company (4.1%)

1.9% - Scope Ophthalmics Limited

4.1% - Industry AVG

employees

Employees

with 74 employees, this is above the industry average (36)

74 - Scope Ophthalmics Limited

36 - Industry AVG

paystructure

Pay Structure

on an average salary of £83.7k, the company has an equivalent pay structure (£81.5k)

£83.7k - Scope Ophthalmics Limited

£81.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £629.4k, this is equally as efficient (£661.5k)

£629.4k - Scope Ophthalmics Limited

£661.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 58 days, this is near the average (58 days)

58 days - Scope Ophthalmics Limited

58 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 131 days, this is slower than average (30 days)

131 days - Scope Ophthalmics Limited

30 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 115 days, this is more than average (65 days)

115 days - Scope Ophthalmics Limited

65 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 14 weeks, this is more cash available to meet short term requirements (11 weeks)

14 weeks - Scope Ophthalmics Limited

11 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 75.9%, this is a higher level of debt than the average (54.4%)

75.9% - Scope Ophthalmics Limited

54.4% - Industry AVG

SCOPE OPHTHALMICS LIMITED financials

EXPORTms excel logo

Scope Ophthalmics Limited's latest turnover from December 2023 is £46.6 million and the company has net assets of £8 million. According to their latest financial statements, Scope Ophthalmics Limited has 74 employees and maintains cash reserves of £6.9 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
Turnover46,576,34542,445,88334,389,71329,428,25529,287,33523,696,18819,043,81014,390,78410,857,5659,805,8947,402,4784,290,289
Other Income Or Grants
Cost Of Sales32,768,36529,417,65524,464,42720,809,78721,010,03716,600,46113,009,9488,695,2636,478,8807,107,9865,344,7083,126,980
Gross Profit13,807,98013,028,2289,925,2868,618,4688,277,2987,095,7276,033,8625,695,5214,378,6852,697,9082,057,7701,163,309
Admin Expenses12,906,10511,375,9157,354,5376,759,6236,687,5186,329,9365,723,5755,612,4934,349,3122,656,7282,031,4191,146,278
Operating Profit901,8751,652,3132,570,7491,858,8451,589,780765,791310,28783,02829,37341,18026,35117,031
Interest Payable
Interest Receivable57,41914,8141,868677154
Pre-Tax Profit959,2941,667,1272,595,1221,860,7151,611,300778,733323,04588,67135,15643,04827,02917,186
Tax-238,328-328,737-502,311-352,840-311,889-151,132-70,445-22,006-10,436-9,040-6,217-4,125
Profit After Tax720,9661,338,3902,092,8111,507,8751,299,411627,601252,60066,66524,72034,00820,81213,061
Dividends Paid
Retained Profit720,9661,338,3902,092,8111,507,8751,299,411627,601252,60066,66524,72034,00820,81213,061
Employee Costs6,190,9445,281,4684,000,3293,450,3363,241,5023,243,8612,807,7212,786,8612,060,660960,500709,082384,606
Number Of Employees74747671626255563319158
EBITDA*901,8751,652,3132,570,7491,858,8451,589,780788,479324,16396,90629,37341,18026,35117,031

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
Tangible Assets22,68836,56450,4427,60310,138
Intangible Assets4,1034,1034,1034,1034,103
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets4,1034,1034,1034,10326,79136,56450,4427,60310,138
Stock & work in progress10,354,64910,144,2595,121,7026,998,0266,866,2813,816,6282,852,6931,231,5571,570,051706,2271,032,250579,076
Trade Debtors7,429,0949,205,4186,588,4666,282,1424,768,9314,590,9434,157,8822,957,8122,655,4252,161,5241,346,265778,911
Group Debtors7,802,7576,722,8704,331,3192,878,3881,481,153
Misc Debtors695,935285,246171,074172,142521,504301,609257,800554,19781,887
Cash6,935,4532,759,5366,795,0043,579,3881,879,1651,969,070437,716188,15591,951538,143209,17561,744
misc current assets
total current assets33,217,88829,117,32923,007,56519,910,08615,517,03410,678,2507,706,0914,931,7214,399,3143,405,8942,587,6901,419,731
total assets33,217,88829,117,32923,011,66819,914,18915,521,13710,682,3537,732,8824,968,2854,449,7563,413,4972,597,8281,419,731
Bank overdraft1,491
Bank loan
Trade Creditors 11,834,1459,266,8135,437,0114,255,8575,086,8853,528,0133,226,4912,239,8641,731,564
Group/Directors Accounts10,532,57110,570,7391,877,385
other short term finances
hp & lease commitments
other current liabilities2,852,1522,001,72311,634,99311,811,4798,095,2746,114,7734,094,4252,569,055746,6153,345,5162,563,8551,406,570
total current liabilities25,218,86821,839,27517,072,00416,067,33613,182,1599,642,7867,320,9164,808,9194,357,0553,345,5162,563,8551,406,570
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities25,218,86821,839,27517,072,00416,067,33613,182,1599,642,7867,320,9164,808,9194,357,0553,345,5162,563,8551,406,570
net assets7,999,0207,278,0545,939,6643,846,8532,338,9781,039,567411,966159,36692,70167,98133,97313,161
total shareholders funds7,999,0207,278,0545,939,6643,846,8532,338,9781,039,567411,966159,36692,70167,98133,97313,161
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012
Operating Activities
Operating Profit901,8751,652,3132,570,7491,858,8451,589,780765,791310,28783,02829,37341,18026,35117,031
Depreciation22,68813,87613,878
Amortisation
Tax-238,328-328,737-502,311-352,840-311,889-151,132-70,445-22,006-10,436-9,040-6,217-4,125
Stock210,3905,022,557-1,876,324131,7453,049,653963,9351,621,136-338,494863,824-326,023453,174579,076
Debtors-285,7485,122,6751,758,1872,561,0841,879,036476,870903,673774,697575,788815,259567,354778,911
Creditors2,567,3323,829,8021,181,154-831,0281,558,872301,522986,627508,3001,731,564
Accruals and Deferred Income850,429-9,633,270-176,4863,716,2051,980,5012,020,3481,525,3701,822,440-2,598,901781,6611,157,2851,406,570
Deferred Taxes & Provisions
Cash flow from operations4,156,666-14,625,1243,191,2431,698,353-111,4251,518,412240,9061,969,437-2,288,012324,565156,89161,489
Investing Activities
capital expenditure-4,103-56,7172,535-10,138
Change in Investments
cash flow from investments-4,103-56,7172,535-10,138
Financing Activities
Bank loans
Group/Directors Accounts-38,16810,570,739-1,877,3851,877,385
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue100
interest57,41914,8141,868677154
cash flow from financing19,25110,585,553-1,877,3851,877,3851,868677254
cash and cash equivalents
cash4,175,917-4,035,4683,215,6161,700,223-89,9051,531,354249,56196,204-446,192328,968147,43161,744
overdraft-1,4911,491
change in cash4,175,917-4,035,4683,215,6161,700,223-89,9051,531,354249,56197,695-447,683328,968147,43161,744

scope ophthalmics limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for scope ophthalmics limited. Get real-time insights into scope ophthalmics limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Scope Ophthalmics Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for scope ophthalmics limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in RH11 area or any other competitors across 12 key performance metrics.

scope ophthalmics limited Ownership

SCOPE OPHTHALMICS LIMITED group structure

Scope Ophthalmics Limited has no subsidiary companies.

Ultimate parent company

SCOPE OPHTHALMICS LIMITED

07883194

SCOPE OPHTHALMICS LIMITED Shareholders

scope opthalmics ltd 100%

scope ophthalmics limited directors

Scope Ophthalmics Limited currently has 2 directors. The longest serving directors include Mr Tom Freyne (Dec 2011) and Mr Laurence Dunne (Aug 2016).

officercountryagestartendrole
Mr Tom FreyneIreland41 years Dec 2011- Director
Mr Laurence DunneIreland56 years Aug 2016- Director

P&L

December 2023

turnover

46.6m

+10%

operating profit

901.9k

-45%

gross margin

29.7%

-3.41%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

8m

+0.1%

total assets

33.2m

+0.14%

cash

6.9m

+1.51%

net assets

Total assets minus all liabilities

scope ophthalmics limited company details

company number

07883194

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

December 2011

age

14

incorporated

UK

ultimate parent company

None

accounts

Full Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

HUGH MCCARTHY & ASSOCIATES

address

unit 4 amberley court, county oak way, crawley, RH11 7XL

Bank

BARCLAYS BANK PLC

Legal Advisor

-

scope ophthalmics limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to scope ophthalmics limited. Currently there are 1 open charges and 1 have been satisfied in the past.

scope ophthalmics limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SCOPE OPHTHALMICS LIMITED. This can take several minutes, an email will notify you when this has completed.

scope ophthalmics limited Companies House Filings - See Documents

datedescriptionview/download